| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30000739 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
| TVIS30031392 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
| TVIS44017284 | HTLV-1 | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CD3D |
|---|---|
| DrugBank ID | DB16678 |
| Drug Name | Talquetamab |
| Target ID | BE0010289 |
| UniProt ID | P20963 |
| Regulation Type | antibody |
| PubMed IDs | 32040549 |
| Citations | Pillarisetti K, Edavettal S, Mendonca M, Li Y, Tornetta M, Babich A, Majewski N, Husovsky M, Reeves D, Walsh E, Chin D, Luistro L, Joseph J, Chu G, Packman K, Shetty S, Elsayed Y, Attar R, Gaudet F: A T-cell-redirecting bispecific G-protein-coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma. Blood. 2020 Apr 9;135(15):1232-1243. doi: 10.1182/blood.2019003342. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
